Abstract
Background
Stigma may contribute to HIV-related disparities among HIV-positive Black Americans.
Purpose
We examined whether social network characteristics moderate stigma’s effects.
Methods
At baseline and 6 months post-baseline, 147 HIV-positive Black Americans on antiretroviral treatment completed egocentric social network assessments, from which we derived a structural social support capacity measure (i.e., ability to leverage support from the network, represented by the average interaction frequency between the participant and each alter). Stigma was operationalized with an indicator of whether any social network member had expressed stigmatizing attributions of blame or responsibility about HIV. Daily medication adherence was monitored electronically.
Results
In a multivariate regression, baseline stigma was significantly related to decreased adherence over time. The association between stigma and non-adherence was attenuated among participants who increased the frequency of their interactions with alters over time.
Conclusions
Well-connected social networks have the potential to buffer the effects of stigma.
Similar content being viewed by others
References
The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Available at http://aids.gov/federal-resources/national-hiv-aids-strategy/nhas.pdf. Accessibility verified March 5, 2014.
Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: Uptake of and responses to antiretroviral therapy. AIDS. 2004; 18: 2145-2151.
Simoni JM, Huh D, Wilson IB, et al. Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. J Acquir Immune Defic Syndr. 2012; 60: 466-472.
Giordano TP, White AC, Sajja P, et al. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003; 32: 399-405.
Centers for Disease Control and Prevention. HIV in the United States: The stages of care. Available at http://www.cdc.gov/hiv/pdf/research_mmp_stagesofcare.pdf. Accessibility verified June 11 2015.
Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: Moving towards resilience. Am Psychol. 2013; 68: 225-236.
Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Ann Behav Med. 2010; 40: 184-190.
Vanable PA, Carey MP, Blair DC, Littlewood RA. Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women. AIDS Behav. 2006; 10: 473-482.
Rajabiun S, Mallinson RK, McCoy K, et al. ‘Getting me back on track’: The role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDS. 2007; 21: S20-S29.
Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: Systematic review and meta-synthesis. J Int AIDS Soc. 2013; 16: 18640.
Pascoe EA, Smart RL. Perceived discrimination and health: A meta-analytic review. Psychol Bull. 2009; 135: 531-554.
Bogart LM, Cowgill BO, Kennedy D, et al. HIV-related stigma among people with HIV and their families: A qualitative analysis. AIDS Behav. 2008; 12: 244-254.
Bogart LM, Chetty S, Giddy J, et al. Barriers to care among people living with HIV in South Africa: Contrasts between patient and healthcare provider perspectives. AIDS Care. 2013; 25: 843-853.
Konkle-Parker DJ, Erlen JA, Dubbert PM. Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care. 2008; 19: 98-104.
Mbonu NC, van den Borne B, De Vries NK. Stigma of people with HIV/AIDS in Sub-Saharan Africa: A literature review. J Trop Med. 2009; 2009: 145891.
Okoror TA, Falade CO, Olorunlana A, Walker EM, Okareh OT. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria. AIDS Patient Care STDS. 2013; 27: 55-64.
Gilbert L, Walker L. ‘My biggest fear was that people would reject me once they knew my status…’: Stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc Care Community. 2010; 18: 139-146.
Bogart LM, Landrine H, Galvan FH, Wagner GJ, Klein DJ. Perceived discrimination and physical health among HIV-positive Black and Latino men who have sex with men. AIDS Behav. 2013; 17: 1431-1441.
Cohen S. Social relationships and health. Am Psychol. 2004; 59: 676-684.
Williams DR, Mohammed SA. Discrimination and racial disparities in health: Evidence and needed research. J Behav Med. 2009; 32: 20-47.
Brondolo E, Rieppi R, Kelly KP, Gerin W. Perceived racism and blood pressure: A review of the literature and conceptual and methodological critique. Ann Behav Med. 2003; 25: 55-65.
Landrine H, Klonoff EA. The schedule of racist events: A measure of racial discrimination and a study of its negative physical and mental health consequences. J Black Psychol. 1996; 22: 144-168.
Janicke DM, Gray WN, Kahhan NA, et al. Brief report: The association between peer victimization, prosocial support, and treatment adherence in children and adolescents with inflammatory bowel disease. J Pediatr Psychol. 2009; 34: 769-773.
Wills TA, Ainette MG. Social Networks and Social Support. In: Baum A, Revenson TA, eds. Handbook of health psychology. New York: Taylor & Francis; 2012: 465-492.
Newsom JT, Rook KS, Nishishiba M, Sorkin DH, Mahan TL. Understanding the relative importance of positive and negative social exchanges: Examining specific domains and appraisals. J Gerontol B Psychol Sci Soc Sci. 2005; 60: 304-P312.
Newsom JT, Mahan TL, Rook KS, Krause N. Stable negative social exchanges and health. Health Psychol. 2008; 27: 78-86.
Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32: 705-714.
McCarty C. Measuring structure in personal networks. J Soc Struct. 2002; 3: 1.
McCarty C, Bernard H, Killworth P, Shelley GA, Johnsen EC. Eliciting representative samples of personal networks. Soc Networks. 1997; 19: 303-323.
Campbell K, Lee B. Name generators in surveys of personal networks. Soc Networks. 1991; 13: 203-221.
McCarty C, Kilworth PD, Rennell J. Impact of methods for reducing respondent burden on personal network structural measures. Soc Networks. 2007; 29: 300-315.
Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991–1999. Am J Public Health. 2002; 92: 371-377.
Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: The Internalized AIDS-Related Stigma Scale. AIDS Care. 2009; 21: 87-93.
Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002; 17: 377-381.
Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000; 14: 357-366.
Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011; 45: 372-379.
Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006; 43: 939-941.
Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr. 2007; 45: 4-8.
Bogart LM, Wagner G, Galvan FH, Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010; 53: 648-655.
Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004; 19: 1111-1117.
Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: Results from a multicenter study. Am J Public Health. 2014; 104: 434-441.
Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: The impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004; 9: 713-719.
Maman S, Abler L, Parker L, et al. A comparison of HIV stigma and discrimination in five international sites: The influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009; 68: 2271-2278.
Green HD, Hoover MA, Wagner GJ, Ryan GW, Ssegujja E. Measuring agreement between egos and alters: Understanding informant accuracy in personal network studies. Field Methods. 2013; 26: 126-140.
Rice E, Milburn NG, Rotheram-Borus MJ. Pro-social and problematic social network influences on HIV/AIDS risk behaviours among newly homeless youth in Los Angeles. AIDS Care. 2007; 19: 697-704.
Valente TW, Vlahov D. Selective risk taking among needle exchange participants: Implications for supplemental interventions. Am J Public Health. 2001; 91: 406-411.
Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users’ personal networks and HIV risk behaviors. Addiction. 2006; 101: 1003-1013.
El-Bassel N, Gilbert L, Wu E, Chang M. A social network profile and HIV risk among men on methadone: Do social networks matter? J Urban Health. 2006; 83: 602-613.
Williams CT, Latkin CA. Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. Am J Prev Med. 2007; 32: S203-S210.
Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: How far have we come? J Int AIDS Soc. 2013; 16: 18734.
Acknowledgments
This study was funded by National Institute of Minority Health and Health Disparities R01MD003964. Support for manuscript preparation was also provided by P30 AI060354. We are grateful to the staff of APLA and SPECTRUM, including Charles Hilliard, PhD, for helping with recruitment and for providing interview space; to Frank Galvan, PhD, for contributions to study design; and to Denedria Banks, Erin Cooper, Sean Jamar Lawrence, Alan Meyer, Argelis Ortiz, and Sandi Paffen for research assistance.
Authors’ Statement of Conflict of Interest and Adherence to Ethical Standards
Authors Bogart, Wagner, Green, Mutchler, Klein, and McDavitt declare that they have no conflict of interest. All procedures, including the informed consent process, were conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bogart, L.M., Wagner, G.J., Green, H.D. et al. Social Network Characteristics Moderate the Association Between Stigmatizing Attributions About HIV and Non-adherence Among Black Americans Living with HIV: a Longitudinal Assessment. ann. behav. med. 49, 865–872 (2015). https://doi.org/10.1007/s12160-015-9724-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12160-015-9724-1